TRACK: Newsletter - Issue 03 - 11 May 2021
Issue 3 | 11 May 2021
Study Overview The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.
Participant Recruitment
Meet the Team
Progress Updates
To remain up to date on site status, visit; https://www.tracktrial.org/participating-sites/